Chun Zhang
About Chun Zhang
Chun Zhang serves as the Chief Technology & Quality Officer at Evelo Biosciences, where he has worked since 2017. He has extensive experience in CMC development, particularly in protein/mAb, gene/cell therapy, and microbiome, with previous roles at Shire and Bayer HealthCare.
Current Role at Evelo Biosciences
Chun Zhang serves as the Chief Technology & Quality Officer at Evelo Biosciences, a position he has held since 2017. In this role, he oversees the technology and quality functions within the organization, ensuring compliance with industry standards and driving innovation in product development. His leadership contributes to the company's focus on advancing therapies related to the microbiome.
Previous Experience at Shire
Chun Zhang held multiple positions at Shire from 2009 to 2017. He served as Sr. Director of Cell Culture Process Development, Pilot Plant, and Commercial Production Support from 2009 to 2012. He then advanced to Vice President & Head of BioProcess Development from 2014 to 2017. His tenure at Shire included responsibilities in manufacturing sciences and operations support, contributing to the development of biopharmaceutical products.
Educational Background
Chun Zhang earned a Ph.D. in Chemical Engineering from the University of Minnesota. He also holds a Bachelor of Science degree in Chemical Engineering from Zhejiang University. His educational background provides a strong foundation for his expertise in biopharmaceutical development and manufacturing.
Expertise in CMC Development
Chun Zhang specializes in Chemistry, Manufacturing, and Controls (CMC) development, particularly in the areas of protein/mAb, gene/cell therapy, and microbiome. His expertise encompasses clinical and commercial manufacturing, packaging, and distribution, making him a valuable asset in the biopharmaceutical industry.
Experience in Outsourcing and Management
Chun Zhang possesses significant experience in outsourcing and management of Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs). His background includes extensive involvement in GMP manufacturing and commercial manufacturing support, as well as corporate strategy and business development.